INTERSECT ENT INC - COM (XENT)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
31,151,538
Share change
+255,875
Total reported value
$775,647,222
Put/Call ratio
14%
Price per share
$24.90
Number of holders
117
Value change
+$11,419,523
Number of buys
57
Number of sells
48

Institutional Holders of INTERSECT ENT INC - COM (XENT) as of Q4 2019

As of 31 Dec 2019, INTERSECT ENT INC - COM (XENT) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,151,538 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., HealthCor Management, L.P., VANGUARD GROUP INC, Point72 Asset Management, L.P., UBS Group AG, First Light Asset Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., and WESTFIELD CAPITAL MANAGEMENT CO LP. This page lists 117 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.